Approve Suite is an AI regulatory platform for biotech quality and regulatory teams. It reads critical records on a schedule, summarizes each new record and says why it matters, matches it against the companies, indications, CFR parts and GxP areas on your watchlist, and delivers the matches in one daily email, with instant alerts for critical items. Ask AI answers your questions about any company, trial or regulation from the same records and cites the events it used. Every item links to its primary source.
Heads of quality and regulatory affairs at clinical-stage biotechs that outsource manufacturing to CDMOs and trials to CROs, and business development at the CDMOs, CROs, consultancies and vendors who sell to them and want to know who was just inspected, funded or approved. It is not built for large pharma quality organizations, for multi-country registration requirements, or for anyone who needs the text of Form 483s.
The free plan shows the last 7 days of records with filters and analytics, the company explorer and profiles, 3 Ask AI questions, and a weekly industry top-5 email. No card is required. Pro is $79 a month or $790 a year and adds your own watchlist, a daily digest at your hour, instant email alerts on critical events, the full archive, and Ask AI at 40 questions a day. You can cancel anytime.
Most records are checked every two to six hours; the ones agencies update once a day are read once a day. Critical items that match your watchlist are emailed within about half an hour of arriving. The daily digest goes out at the hour you pick.
Ask AI answers questions about FDA actions, trials, companies, filings and the regulations behind them using only the data in the product, and cites the events it used. Free accounts get 3 questions to try it; Pro accounts get 40 questions a day. Questions outside the life-science industry are declined.
Open Watchlist, pick Competitor, Supplier, CRO or Prospect, and type the company's name. Modalities, therapeutic areas, indications, keywords, GxP areas, CFR parts and regulatory topics go in the sections below it. Companies are matched under every name they appear under, so a subsidiary or an old name still matches.